Electronic Code of Federal Regulations

We invite you to try out our new beta eCFR site at https://ecfr.federalregister.gov. We have made big changes to make the eCFR easier to use. Be sure to leave feedback using the Feedback button on the bottom right of each page!

e-CFR data is current as of March 4, 2021

Title 21 → Chapter I → Subchapter E → Part 522 → §522.870

Browse Previous | Browse Next

Title 21: Food and Drugs
PART 522—IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS

§522.870 Etodolac.

(a) Specifications. Each milliliter contains 100 milligrams (mg) etodolac.

(b) Sponsor. See No. 000010 in §510.600 of this chapter.

(c) Conditions of use in dogs—(1) Amount. Administer 4.5 to 6.8 mg/pound (10 to 15 mg/kilogram) body weight as a single, dorsoscapular subcutaneous injection. If needed, the daily dose of etodolac tablets as in §520.870 of this chapter may be given 24 hours after the injection.

(2) Indications for use. For the control of pain and inflammation associated with osteoarthritis.

(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

[72 FR 51365, Sept. 7, 2007, as amended at 75 FR 10167, Mar. 5, 2010]

Need assistance?